A Narrative Review of Myths and Misconceptions About Methylphenidate in the Treatment of Attention-Deficit/Hyperactivity Disorder

CONCLUSIONS: MPH remains a well-studied, effective, and generally well-tolerated treatment for ADHD in children, adolescents, and adults. The diversity of available formulations, including novel delivery systems such as delayed-release/extended-release MPH and serdexmethylphenidate/dexmethylphenidate, allows for individualized treatment matched to patient needs and daily functional demands. Clinicians who understand evidence-based rebuttals to myths about MPH can improve prescribing decisions…

via https://pubmed.ncbi.nlm.nih.gov/43061900/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1HYeX0emtvYgH07Wkz0a8n9otrdMd-JIklc_uo0I5vh1u9WMEy&fc=None&ff=20261121020805&v=2.20.1


Post a Comment

Your email is never published nor shared. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>